Thomas Skovlund Schnegelsberg

Co-founder & CEO, Stenocare

When Thomas co-founded Stenocare in 2017, he was seeking to provide high-quality medical cannabis products in Denmark and Europe. The company is licensed to cultivate and produce medical cannabis in Denmark but also imports and sells finished products from Canadian producers. Under Thomas’ leadership, Stenocare in 2018 became the first licensed producer to go public in Europe. Before launching Stenocare, Thomas served in executive management roles with Microsoft and Philips.


European Symposium Session:

Business & Investing Opportunities:
Raising Capital in Europe

6 May 2019 | 14:20 - 14:50